Select New to Market Drugs — Highmark

Initial criteria

• Medication must be used for an FDA-approved indication
• If medication is an authorized generic, member has experienced therapeutic failure, contraindication, or intolerance to the respective brand product AND all other plan-preferred products in the medication’s therapeutic category
• If request is for a new to market oral liquid dosage form of a chemical entity that is commercially available as a solid oral dosage form, member has met criteria outlined in policy J-1283

Approval duration

6 months